Eli Lilly's bid for Kelonia Therapeutics cleared in Australia
MLex Summary: Eli Lilly's proposal to wholly acquire Kelonia Therapeutics has been approved by Australia's competition watchdog. In a determination issued on Wednesday, the Australian Competition & Consumer Commission said that...To view the full article, register now.
Already a subscriber? Click here to view full article